Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.64 |
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
| ▸ | RAB9A | P51151 | 4/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2253260 | 1.00 | ALDH1A1 (0.64) | ALDH1A1HPGDRAB9AL3MBTL1CYP2C9 | |
| SCHEMBL2253256 | 1.00 | ALDH1A1 (0.64) | ALDH1A1HPGDRAB9AL3MBTL1CYP2C9 | |
| SCHEMBL2252906 | 0.83 | POLB (0.55) | ALDH1A1HPGDRAB9AL3MBTL1CYP2C9 | |
| SCHEMBL2252910 | 0.83 | POLB (0.55) | ALDH1A1HPGDRAB9AL3MBTL1CYP2C9 | |
| SCHEMBL2252176 | 0.83 | ALDH1A1 (0.56) | ALDH1A1HPGDRAB9AL3MBTL1CYP2C9 | |
| SCHEMBL2252899 | 0.83 | POLB (0.55) | ALDH1A1HPGDRAB9AL3MBTL1CYP2C9 | |
| SCHEMBL2252182 | 0.83 | ALDH1A1 (0.56) | ALDH1A1HPGDRAB9AL3MBTL1CYP2C9 | |
| SCHEMBL2252180 | 0.83 | ALDH1A1 (0.56) | ALDH1A1HPGDRAB9AL3MBTL1CYP2C9 | |
| SCHEMBL2256648 | 0.81 | ALDH1A1 (0.60) | ALDH1A1HPGDRAB9AL3MBTL1CYP2C9 | |
| SCHEMBL2256653 | 0.81 | ALDH1A1 (0.60) | ALDH1A1HPGDRAB9AL3MBTL1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2531503-A1 | GAMMA SECRETASE MODULATERS | F. Hoffmann-La Roche AG (CH) | 2012-12-12 | — | — | EP | disclosed |
| WO-2011092272-A1 | GAMMA SECRETASE MODULATERS | F. HOFFMANN-LA ROCHE AG (CH) | 2011-08-04 | — | — | WO | disclosed |
| US-20110190269-A1 | GAMMA SECRETASE MODULATORS | HOFFMANN-LA ROCHE, INC. | 2011-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190269-A1 | GAMMA SECRETASE MODULATORS | BACE1, APH1A, APH1B | ALDH1A1 2136/4885HPGD 181/4885RAB9A 1923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.